Oestrogen receptor β mediates the actions of bisphenol-A on ion channel expression in mouse pancreatic beta cells

Empreu sempre aquest identificador per citar o enllaçar aquest ítem http://hdl.handle.net/10045/95669
Información del item - Informació de l'item - Item information
Títol: Oestrogen receptor β mediates the actions of bisphenol-A on ion channel expression in mouse pancreatic beta cells
Autors: Martinez-Pinna, Juan | Marroquí, Laura | Hmadcha, Abdelkrim | Lopez-Beas, Javier | Soriano, Sergi | Villar-Pazos, Sabrina | Alonso Magdalena, Paloma | Dos Santos, Reinaldo S. | Quesada, Iván | Martin, Franz | Soria, Bernat | Gustafsson, Jan-Ake | Nadal, Ángel
Grups d'investigació o GITE: Fisiología Neuroendocrina (FINE)
Centre, Departament o Servei: Universidad de Alicante. Departamento de Fisiología, Genética y Microbiología
Paraules clau: Beta cell | Bisphenol-A | Diabetes | Endocrine-disrupting chemicals | K+ channels | Na+ channels | Oestrogen receptor β
Àrees de coneixement: Fisiología
Data de publicació: de setembre-2019
Editor: Springer Berlin Heidelberg
Citació bibliogràfica: Diabetologia. 2019, 62(9): 1667-1680. doi:10.1007/s00125-019-4925-y
Resum: Aims/hypothesis Bisphenol-A (BPA) is a widespread endocrine-disrupting chemical that has been associated with type 2 diabetes development. Low doses of BPA modify pancreatic beta cell function and induce insulin resistance; some of these effects are mediated via activation of oestrogen receptors α (ERα) and β (ERβ). Here we investigated whether low doses of BPA regulate the expression and function of ion channel subunits involved in beta cell function. Methods Microarray gene profiling of isolated islets from vehicle- and BPA-treated (100 μg/kg per day for 4 days) mice was performed using Affymetrix GeneChip Mouse Genome 430.2 Array. Expression level analysis was performed using the normalisation method based on the processing algorithm ‘robust multi-array average’. Whole islets or dispersed islets from C57BL/6J or oestrogen receptor β (ERβ) knockout (Erβ−/−) mice were treated with vehicle or BPA (1 nmol/l) for 48 h. Whole-cell patch-clamp recordings were used to measure Na+ and K+ currents. mRNA expression was evaluated by quantitative real-time PCR. Results Microarray analysis showed that BPA modulated the expression of 1440 probe sets (1192 upregulated and 248 downregulated genes). Of these, more than 50 genes, including Scn9a, Kcnb2, Kcnma1 and Kcnip1, encoded important Na+ and K+ channel subunits. These findings were confirmed by quantitative RT-PCR in islets from C57BL/6J BPA-treated mice or whole islets treated ex vivo. Electrophysiological measurements showed a decrease in both Na+ and K+ currents in BPA-treated islets. The pharmacological profile indicated that BPA reduced currents mediated by voltage-activated K+ channels (Kv2.1/2.2 channels) and large-conductance Ca2+-activated K+ channels (KCa1.1 channels), which agrees with BPA’s effects on gene expression. Beta cells from ERβ−/− mice did not present BPA-induced changes, suggesting that ERβ mediates BPA’s effects in pancreatic islets. Finally, BPA increased burst duration, reduced the amplitude of the action potential and enlarged the action potential half-width, leading to alteration in beta cell electrical activity. Conclusions/interpretation Our data suggest that BPA modulates the expression and function of Na+ and K+ channels via ERβ in mouse pancreatic islets. Furthermore, BPA alters beta cell electrical activity. Altogether, these BPA-induced changes in beta cells might play a role in the diabetogenic action of BPA described in animal models.
Patrocinadors: This work was supported by Ministerio de Economía y Competitividad, Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional (FEDER) grants BPU2017-86579-R and SAF2014-58335-P (AN) and BFU2016-77125-R (IQ); Generalitat Valenciana PROMETEO II/2015/016 (AN); Grant for Networks of Excellence from MICINN ‘Nuclear Receptors in Cancer, Metabolism and Inflammation’ (NuRCaMeIn) (SAF2017-90604-REDT); Spanish Institute of Health Carlos III grants PI16/00259 (AH), PI17/02104 and RD16/0011/0034 (BS) co-financed by FEDER Funds. LM holds a Juan de la Cierva fellowship from the Ministry of Economy, Industry and Competitiveness (IJCI-2015-24482). CIBERDEM is an initiative of the Instituto de Salud Carlos III. J-AG was supported by the Robert A.Welch Foundation (E-0004).
URI: http://hdl.handle.net/10045/95669
ISSN: 0012-186X (Print) | 1432-0428 (Online)
DOI: 10.1007/s00125-019-4925-y
Idioma: eng
Tipus: info:eu-repo/semantics/article
Drets: © Springer-Verlag GmbH Germany, part of Springer Nature 2019
Revisió científica: si
Versió de l'editor: https://doi.org/10.1007/s00125-019-4925-y
Apareix a la col·lecció: INV - FINE - Artículos de Revistas

Arxius per aquest ítem:
Arxius per aquest ítem:
Arxiu Descripció Tamany Format  
Thumbnail2019_Martinez-Pinna_etal_Diabetologia_final.pdfVersión final (acceso restringido)1,8 MBAdobe PDFObrir     Sol·licitar una còpia


Tots els documents dipositats a RUA estan protegits per drets d'autors. Alguns drets reservats.